Naproxen Sodium

DR. REDDY'S LABORATORIES LIMITED Hy...

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

India

Virtual Booth

Digital Content

Naproxen sodium, Cuernavaca, Mexico site

Certificate Number

R1-CEP 2008-110 - Rev 01

Status

Valid

Type

Chemical

Issue Date

2015-06-10

End Date

Substance Number

1702

01

DR. REDDY'S LABORATORIES LIMITED Hy...

India

CPhI India 2024

Booth #RH.E02

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

India

Virtual Booth

Digital Content

Naproxen sodium, Cuernavaca, Mexico site

Certificate Number : R1-CEP 2008-110 - Rev 01

Status : Valid

Issue Date : 2015-06-10

Type : Chemical

Substance Number : 1702

DR. REDDY'S LABORATORIES LIMITED Hy...

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

India

Virtual Booth

Digital Content

Certificate Number

R1-CEP 2008-068 - Rev 03

Status

Valid

Type

Chemical

Issue Date

2019-06-21

End Date

Substance Number

1702

02

DR. REDDY'S LABORATORIES LIMITED Hy...

India

CPhI India 2024

Booth #RH.E02

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

India

Virtual Booth

Digital Content

Naproxen sodium

Certificate Number : R1-CEP 2008-068 - Rev 03

Status : Valid

Issue Date : 2019-06-21

Type : Chemical

Substance Number : 1702

AUROBINDO PHARMA LIMITED Hyderabad ...

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

India

Virtual Booth

Digital Content

Naproxen sodium

Portfolio PDF

Product Web Link

Certificate Number

R1-CEP 2009-085 - Rev 00

Status

Valid

Type

Chemical

Issue Date

2015-11-10

End Date

Substance Number

1702

03

AUROBINDO PHARMA LIMITED Hyderabad ...

India

2024 ACI Convention

Not Confirmed

Zhejiang Charioteer Pharmaceutical ...

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

China

Virtual Booth

Digital Content

Naproxen sodium

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Certificate Number

R1-CEP 2010-021 - Rev 01

Status

Valid

Type

Chemical

Issue Date

2018-02-22

End Date

Substance Number

1702

04

Zhejiang Charioteer Pharmaceutical ...

China

2024 ACI Convention

Not Confirmed

DIVI'S LABORATORIES LIMITED Hyderab...

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

India

Virtual Booth

Digital Content

Naproxen sodium

Product Web Link

Corporate PDF

Certificate Number

R1-CEP 2007-110 - Rev 04

Status

Valid

Type

Chemical

Issue Date

2021-10-21

End Date

Substance Number

1702

05

DIVI'S LABORATORIES LIMITED Hyderab...

India

2024 ACI Convention

Not Confirmed

HETERO LABS LIMITED Hyderabad IN

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

India

Virtual Booth

Digital Content

Naproxen sodium

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Certificate Number

CEP 2022-389 - Rev 00

Status

Valid

Type

Chemical

Issue Date

2024-09-13

End Date

Substance Number

1702

06

HETERO LABS LIMITED Hyderabad IN

India

2024 ACI Convention

Not Confirmed

TEVA PHARMACEUTICAL INDUSTRIES LTD ...

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Israel

Virtual Booth

Digital Content

Naproxen sodium

Product Web Link

Corporate PDF

Certificate Number

R1-CEP 2007-047 - Rev 05

Status

Valid

Type

Chemical

Issue Date

2022-03-24

End Date

Substance Number

1702

07

TEVA PHARMACEUTICAL INDUSTRIES LTD ...

Israel

2024 ACI Convention

Not Confirmed

GRANULES INDIA LIMITED Hyderabad IN

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Gabon

Virtual Booth

Digital Content

Naproxen sodium

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Certificate Number

R0-CEP 2020-106 - Rev 00

Status

Withdrawn by Holder

Type

Chemical

Issue Date

2021-06-28

End Date

2023-09-11

Substance Number

1702

08

GRANULES INDIA LIMITED Hyderabad IN

Gabon

2024 ACI Convention

Not Confirmed

Naproxen Sodium

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

29 API Suppliers

22 USDMF

7 CEP/COS

4 EU WC

34 KDMF

11 NDC API

9 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

6 Drugs in Development

FINISHED DOSAGE FORMULATIONS

148 FDF Dossiers

85 FDA Orange Book

11 Europe

18 Canada

4 South Africa

30 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 500MG BASE

TABLET;ORAL - 220MG

TABLET, EXTENDED RELEASE;ORAL - EQ 375MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 500MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 750MG BASE

CAPSULE;ORAL - EQ 200MG BASE

TABLET;ORAL - 500MG;EQ 85MG BASE

TABLET;ORAL - 60MG;EQ 10MG BASE

RELATED EXCIPIENT COMPANIES

3 Evonik

4 Rochem International Inc

19 SPI Pharma

2 Seqens

9 DKSH

2 Jai Radhe Sales

11 Boai NKY Pharmaceuticals Ltd

14 Gangwal Healthcare

11 Nanjing Well Pharmaceutical

2 Pfanstiehl

4 ACG Worldwide

11 Actylis

2 Aeon Procare

1 Alcedo Pharmachem

10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

33 BASF

3 Clariant

17 Corel Pharma Chem

6 DFE Pharma

2 Finar

13 Gangwal Chemicals

11 Ideal Cures Pvt Ltd

5 Ingredion Pharma Solutions

33 Kerry

4 Kima Chemical

6 Lonza Capsugel

20 Microlex e.U

1 Nanjing Bold Chemical

2 Nomisma Healthcare

4 Novo Excipients

4 Pharmatrans-Sanaq

9 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

38 Roquette

13 Seppic

7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

2 Shijiazhuang Huaxu Pharmaceutical

12 Sigachi Industries

3 The Dow Chemical Company

4 Ulanqab Kema New Material

1 Valens Pharmachem

4 Vasa Pharmachem

1 Vertellus

TABLET;ORAL - EQ 250MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons